Cafepharma Today

May 14 2025 - AbbVie pays ADARx $335M cash for next-gen siRNA options
AbbVie pays ADARx $335M cash for next-gen siRNA options
Novo Nordisk inks $2.2B deal for Septerna's preclinical obesity programs
Roche reports final overall survival outcomes from breast cancer treatment trial
GSK buys phase III–ready liver drug in potential $2B deal to play in MASH arena
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Biogen says potential MS drug outperforms placebo
Yahoo/AP
Friday, October 21, 2011 - 10:09am
tags:
MS, Biogen Idec, multiple sclerosis, BG-12
AMAG Didn’t Get Sufficient Votes for Acquisition of Allos
Bloomberg
Friday, October 21, 2011 - 10:07am
tags:
Amag Pharmaceuticals, M&A, Allos
J&J, Novartis Face EU Antitrust Probe on Generics
Bloomberg
Friday, October 21, 2011 - 10:01am
tags:
JNJ, Europe, Novartis, antitrust, generics
Abbott Spinoff Unlikely to Attract Takeover Bid, Bernstein Says
Bloomberg
Friday, October 21, 2011 - 10:00am
tags:
Abbott Laboratories, M&A, spinoff
Dividend Battle: Procter & Gamble Vs. Johnson & Johnson
Seeking Alpha
Friday, October 21, 2011 - 9:58am
tags:
P&G, JNJ, dividends
Abbott May Be Doing The Right Thing At The Wrong Time
Seeking Alpha
Friday, October 21, 2011 - 9:57am
tags:
Abbott Laboratories, reorganization, Amgen, Biogen Idec, Bristol-Myers Squibb, GSK, JNJ, Boston Scientific, Medtronic, Pfizer, Roche, Pharmasset
Amgen 3Q report to focus on key drug sales trends
Yahoo/AP
Friday, October 21, 2011 - 9:55am
tags:
earnings, Amgen
Pfizer Settles Detrol Whistle-Blower Suit
Bloomberg
Thursday, October 20, 2011 - 1:03pm
tags:
Detrol, whistleblower lawsuits, off-label
Vertex CEO sees "historic launch" for Hep-C drug
Reuters
Thursday, October 20, 2011 - 12:51pm
tags:
hepatitis C, Vertex, Pharma CEOs, Incivek, Matthew Emmens
Study: Pradaxa use results in higher per-patient costs
Fierce Pharma
Thursday, October 20, 2011 - 12:49pm
tags:
Boehringer Ingelheim, Pradaxa, bloodthinners, Warfarin
Will Emerging Markets Really Save Pharma?
Pharmalot
Thursday, October 20, 2011 - 12:46pm
tags:
emerging markets
Immunogen begins mid-stage testing of experimental cancer compound, triggers $3M payment
Yahoo/AP
Thursday, October 20, 2011 - 12:45pm
tags:
Immunogen, Sanofi, SAR3419, non-Hodgkin's lymphoma
Inside Human Genome Sciences’s Upcoming Earnings Release
Yahoo/Wall St. Cheat Sheet
Thursday, October 20, 2011 - 12:44pm
tags:
earnings, Human Genome Sciences
Alexion 3Q profit rises on growing Soliris sales
Yahoo/AP
Thursday, October 20, 2011 - 12:38pm
tags:
Soliris, earnings, Alexion
Impax Settles With Abbott, Fournier to Sell Generic TriLipix
Bloomberg
Thursday, October 20, 2011 - 12:37pm
tags:
Impax, Abbott Laboratories, Fournier, generics, TriLipix
Actelion Plunges After Forecasting Declining Sales in 2012
Bloomberg
Thursday, October 20, 2011 - 9:23am
tags:
guidance, earnings, Actelion
More than one in 10 Americans use antidepressants
Reuters
Thursday, October 20, 2011 - 9:22am
tags:
antidepressants
Cubist says 3Q profit falls, but raises outlook
Yahoo/AP
Thursday, October 20, 2011 - 9:21am
tags:
earnings, Cubist
Biogen Idec, Elan Say FDA Extends Date to Decide Tysabri Change
Bloomberg
Thursday, October 20, 2011 - 9:17am
tags:
Biogen Idec, FDA, Elan, Tysabri, MS, multiple sclerosis
Amgen To Lay Off Nearly 400 Employees
Pharmalot
Thursday, October 20, 2011 - 9:09am
tags:
Amgen, layoffs

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline
Defluorination is Happening Inside You Right Now
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.